Related Experiment Video
Updated: Aug 8, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Lupus band test and disease activity in systemic lupus erythematosus: does it still matter?
R D Zecević1, M D Pavlović, D Stefanović
1Department of Dermatology, Military Medical Academy, Belgrade, Serbia and Montenegro.
Insights
The lupus band test (LBT) on sun-protected skin may indicate severe systemic lupus erythematosus (SLE) at diagnosis. A positive LBT, especially with multiple immunoglobulin deposits, correlates with higher disease activity.
Area of Science:
- Immunodermatology
- Rheumatology
- Systemic Lupus Erythematosus Research
Background:
- The diagnostic and disease activity assessment roles of the lupus band test (LBT) in systemic lupus erythematosus (SLE) remain undefined.
- Current understanding lacks clarity on the clinical significance of LBT in SLE management.
Purpose of the Study:
- To investigate the correlation between a positive lupus band test (LBT) and the global disease activity in patients with systemic lupus erythematosus (SLE).
- To determine if LBT findings can serve as a marker for disease severity in SLE.
Main Methods:
- Prospective study of 90 SLE patients undergoing biopsy of sun-protected, non-lesional (SPNL) skin.
- Direct immunofluorescence analysis of skin specimens.
- Classification of patients based on LBT results (negative/positive) and SLE Disease Activity Index (SLEDAI) scoring.
Main Results:
- A positive LBT was significantly associated with higher SLE disease activity.
- Increased numbers of deposited immunoreactants correlated with more active disease.
- Nearly all patients with renal involvement exhibited a positive LBT.
Conclusions:
- Lupus band test on SPNL skin may signify severe SLE at initial presentation.
- The presence of three immunoglobulins at the dermoepidermal junction strengthens LBT's potential as a marker for severe SLE.
Background:
Lupus band test still has no clearly defined position within either diagnostic or disease activity measuring tools for systemic lupus erythematosus (SLE).
Objectives:
We tested the hypothesis that positive LBT correlates with global activity of SLE measured by the SLE Disease Activity Index (SLEDAI) score.
Methods:
In total, 90 SLE patients who underwent biopsy of sunprotected non-lesional (SPNL) skin were studied prospectively. The skin specimen was processed for standard direct immunofluorescence. The patients were classified into groups as negative and positive LBT, and the latter were further subdivided on the basis of the type and morphology of the deposits. Every patient was thoroughly examined and assigned a SLEDAI score. The relationship between LBT findings and SLEDAI score was analysed.
Results:
The disease was significantly more active in patients with positive LBT and in those with a higher number of deposited immunoreactants. Almost all patients with renal involvement had a positive LBT.
Conclusions:
LBT on SPNL skin may be a good marker of severe disease at presentation, particularly when three immunoglobulins are found at the dermoepidermal junction.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Nephrotic Syndrome II : Assessment and Medical Management
